Endurance Wealth Management, Inc. Dbv Technologies S.A. Transaction History

Endurance Wealth Management, Inc.

  • $731 Million
  • Q2 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 27, 2020
SELL
$1.58 - $4.77 $1,580 - $4,770
-1,000 Closed
0 $0
Q4 2019

Jan 14, 2020
BUY
$6.75 - $11.15 $6,750 - $11,150
1,000 New
1,000 $11,000

Others Institutions Holding DBVT

# of Institutions
2
Shares Held
3.2K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $1.5B
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Endurance Wealth Management, Inc. Portfolio

Follow Endurance Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email